Advertisement

European Journal of Clinical Pharmacology

, Volume 3, Issue 3, pp 148–152 | Cite as

Clinical trial of intravenous dextro-alprenolol in cardiac arrhythmias

  • R. Gatzinska
  • R. Henning
  • G. Nyberg
  • B. Olsson
  • L. Orö
  • L. Werkö
Originals

Summary

D-alprenolol, in doses of 50–170 mg, was given intravenously to 23 patients with various cardiac arrhythmias. Seven patients had acute myocardial infarction, ten patients had chronic ischemic heart disease with rhythm disturbances, three were in congestive failure and one had myocarditis. The ventricular arrhythmias were abolished in several patients. In some of the patients with compromised myocardial function, the blood pressure dropped markedly and heart rate slowed to a degree requiring treatment. These effects have been seen after other β-adrenergic blocking agents, and were considered to be due mainly to the cardiodepressive action of D-alprenolol in the doses used. Because of these potentially dangerous side effects, and because little benefit was apparent over other drugs, it was concluded that D-alprenolol should not be used for the treatment of arrhythmias in patients who have myocardial damage.

Key-words

D-alprenolol heart arrhythmias 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Åblad, B.: Personal communication.Google Scholar
  2. 2.
    Belliveau, R.E., Covino, B.G.: Effects of a new β-adrenergic receptor blocking agent, alprenolol, and its optical isomers. Arch. int. Pharmacodyn.180, 341–349 (1969).Google Scholar
  3. 3.
    Brändström, A.: Personal communication.Google Scholar
  4. 4.
    Duce, B.R., Garberg, L.: Effect of alprenolol — a new beta-adrenergic receptor blocking agent and its optical isomers on arrhythmias following coronary artery occlusion in dogs. Fed. Proc.28, 477 (1969).Google Scholar
  5. 5.
    —— —— Johansson, B.: The effect of prepranolol and the dextro and laevo isomers of H 56/28 upon ouabain-induced ventricular tachycardia in unanaesthetized dogs. Acta Pharmacol.25, suppl. 2, 41–49 (1967).Google Scholar
  6. 6.
    Ekelund, I.-G., Melcher, A., Orö, L.: Central haemodynamic effects of the dextro-isomer of alprenolol infused into man at rest and during exercise. In preparation.Google Scholar
  7. 7.
    Gibson, D., Sowton, E.: The use of beta-adrenergic receptor blocking drugs in dysrhythmias. Progress in Cardiovasc. Dis.12, 16–39 (1969).Google Scholar
  8. 8.
    Howe, R., Shanks, R. G.: Optical isomers of propranolol. Nature210, 1336–1338 (1966).Google Scholar
  9. 9.
    Katz, R.L., Lord, C.O., Eakins, K.E.: Anesthetic-dopamine cardiac arrhythmias and their prevention by betaadrenergic blockade. J. Pharmacol. exp. Ther.158, 40–45 (1967).Google Scholar
  10. 10.
    Kreus, K.-E., Salokannel, S.J., Isomäki, H., Waris, E.K.: Alprenolol in the treatment of arrhythmias in acute coronary patients. Acta med. scand.188, 375–378 (1970).Google Scholar
  11. 11.
    Linko, E., Ruosteenoja, R., Siitonen, L.: A clinical study on the mechanism of the antiarrhythmic action of a new antagonist to beta-adrenergic receptors. Amer. Heart J.75, 139–140 (1968).Google Scholar
  12. 12.
    Lord, C.O., Katz, R.L., Eakins, E.K.: Anti-arrhythmic properties of stereoisomers of a beta-adrenergic blocking agent (H 56/28). Anesthesiology29, 288–294 (1968).Google Scholar
  13. 13.
    Lucchesi, B.R.: The effects of prenethalol and its dextro isomer upon experimental cardiac arrhythmias. J. Pharmacol. exp. Ther.148, 94–99 (1965).Google Scholar
  14. 14.
    —— Whitsite, L.S., Iwami, T.: Effect of propranolol and its dextro-isomer on experimentally induced arrhythmias. In: Kattus, Ross, Hall (Ed.): Beta adrenergic responses. P. 21. Univ. of Cal. Press, Berkeley, 1970.Google Scholar
  15. 15.
    Madan, B.R., Mischra, S.N., Khanna, V.K.: Effect of dextro-and laevo rotary isomers of H56/28 on experimental ventricular arrhythmias. Arch. int. Pharmacodyn.182, 121–129 (1969).Google Scholar
  16. 16.
    Saunamäki, K.: Studies on the anti-arrhythmic effect of dextro-alprenolol. Investigation of the anti-arrhythmic affect of dextro-alprenolol. Europ. J. Clin. Pharmacol.3, 23–31 (1970).Google Scholar
  17. 17.
    Sowton, E., Bennett, D., Smith, E., Balcon, R., Gibson, D.: Antidysrythmic effects of beta-blocking drugs. in: Symposium on Cardiac Arrhythmias, Elsinore, Denmark, 1970 p. 479–493.Google Scholar
  18. 18.
    Vohra, J.K., Thompson, P.L., Sloman, J.G.: Clinical experience with dextro-alprenolol. Brit. med. J.1970 I, 791–792.Google Scholar

Copyright information

© Springer-Verlag 1971

Authors and Affiliations

  • R. Gatzinska
    • 1
    • 2
  • R. Henning
    • 1
    • 2
  • G. Nyberg
    • 1
    • 2
  • B. Olsson
    • 1
    • 2
  • L. Orö
    • 1
    • 2
  • L. Werkö
    • 1
    • 2
  1. 1.First Department of Medicine, Sahlgren HospitalUniversity of Göteborg, Clinic I, Vasa HospitalGöteborgSweden
  2. 2.the Coronary Care Unit, Department of MedicineKarolinska Hospital and King Gustaf V Research InstituteStockholmSweden

Personalised recommendations